Esperion Therapeutics, Inc. (ESPR)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.9200 |
| Open | 3.9000 |
| Bid | 3.6000 x 2200 |
| Ask | 3.7900 x 4000 |
| Day's Range | 3.6400 - 4.0200 |
| 52 Week Range | 3.5800 - 36.9000 |
| Volume | |
| Avg. Volume | 2,250,179 |
| Market Cap | 227.45M |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -11.6890 |
| Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13.18 |
- GlobeNewswire
Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to $240 Million – ANN ARBOR, Mich., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced preliminary, unaudited fourth-quarter 2021 financial res
- GlobeNewswire
Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference
ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern Time. Event:J.P. Morgan 40th Annual Healthcare ConferenceDate:Thursday, January 13, 2022Format:Presentation and 1:1 MeetingsTime:10:30 a.m. ET Live audio webcasts of these events can be accessed on the investor re
- GuruFocus.com
Meditor Group Ltd Buys Esperion Therapeutics Inc, Sells BTC iShares MSCI India ETF, WisdomTree ...
Hamilton, D0, based Investment company Meditor Group Ltd (Current Portfolio) buys Esperion Therapeutics Inc, sells BTC iShares MSCI India ETF, WisdomTree India Earnings Fund during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Meditor Group Ltd.
